StockData
Kodiak Sciences Inc. logo

Kodiak Sciences Inc. (KOD) stock

KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$96.80−3.93 (-3.90%)

Close on Nov 17, 2026Market cap $6.08BP/E –Yield –

Kodiak Sciences total assets

Total assets on the balance sheet at the end of each period.

Kodiak Sciences's total assets was $256.81M at Jun 30, 2026. For fiscal 2025 it was $351.53M, up 4.8% from the year before. The highest annual figure on record is $1.07B in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$351.53M+4.8%
FY2024Dec 31, 2024$335.58M-30.0%
FY2023Dec 31, 2023$479.37M-28.1%
FY2022Dec 31, 2022$666.63M-26.3%
FY2021Dec 31, 2021$904.22M-15.3%
FY2020Dec 31, 2020$1.07B+197.4%
FY2019Dec 31, 2019$358.87M+289.3%
FY2018Dec 31, 2018$92.19M+2741.8%
FY2017Dec 31, 2017$3.24M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$256.81M+0.0%
Q1 FY2026Mar 31, 2026$306.01M+2.7%
Q4 FY2025Dec 31, 2025$351.53M+4.8%
Q3 FY2025Sep 30, 2025$218.07M-41.5%
Q2 FY2025Jun 30, 2025$256.73M-36.1%
Q1 FY2025Mar 31, 2025$297.91M-31.5%
Q4 FY2024Dec 31, 2024$335.58M-30.0%
Q3 FY2024Sep 30, 2024$372.67M-32.0%
Q2 FY2024Jun 30, 2024$401.58M-31.9%
Q1 FY2024Mar 31, 2024$434.76M-32.1%
Q4 FY2023Dec 31, 2023$479.37M-28.1%
Q3 FY2023Sep 30, 2023$547.65M-24.4%
Q2 FY2023Jun 30, 2023$589.66M-24.6%
Q1 FY2023Mar 31, 2023$640.33M-24.7%
Q4 FY2022Dec 31, 2022$666.63M-26.3%
Q3 FY2022Sep 30, 2022$723.99M-24.4%
Q2 FY2022Jun 30, 2022$781.91M-21.6%
Q1 FY2022Mar 31, 2022$850.29M-17.7%
Q4 FY2021Dec 31, 2021$904.22M-15.3%
Q3 FY2021Sep 30, 2021$958.21M+99.3%
Q2 FY2021Jun 30, 2021$997.60M+132.3%
Q1 FY2021Mar 31, 2021$1.03B+133.1%
Q4 FY2020Dec 31, 2020$1.07B+197.4%
Q3 FY2020Sep 30, 2020$480.74M+597.6%
Q2 FY2020Jun 30, 2020$429.37M+448.5%
Q1 FY2020Mar 31, 2020$443.04M+408.8%
Q4 FY2019Dec 31, 2019$358.87M+289.3%
Q3 FY2019Sep 30, 2019$68.92M+302.7%
Q2 FY2019Jun 30, 2019$78.28M+2312.9%
Q1 FY2019Mar 31, 2019$87.08M–
Q4 FY2018Dec 31, 2018$92.19M–
Q3 FY2018Sep 30, 2018$17.12M–
Q4 FY2017Dec 31, 2017$3.24M–

More Kodiak Sciences figures

See a number that looks wrong?